BMJ  2006;332:677-678 (25 March), doi:10.1136/bmj.38797.635012.47 (published 22 March 2006)

Editorial

Learning from the TGN1412 trial

This experience should foster an open culture in medical research

The first 150 words of the full text of this article appear below.

Earlier this month eight healthy volunteers in a phase I trial received a T cell agonist at Parexel's clinical pharmacology research unit at Northwick Park Hospital, London.¹ The six men who received the active component rapidly developed catastrophic multisystem failure; the remaining two, who received a placebo, were unharmed. At the time of going to press, two remained in a critical condition. This was the first human trial of TeGenero's TGN1412, a new humanised monoclonal superagonist of the CD28 T cell surface receptor,² designed to mitigate autoimmune and immunodeficiency disease.

This allegedly unprecedented event in clinical research represents a very human tragedy, one which will probably change for ever the face of clinical drug development and testing, and one which gives us the opportunity to learn many valuable lessons. A system based approach to learning is more likely to generate useful outcomes than one that is narrowly explanatory and . . . [Full text of this article]

Questions raised by the trial

A more transparent culture

Department of Medicine, Dalhousie University, Halifax, NS, Canada B3H 2Y9
(MGoodyea@dal.ca)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Research consortium highlights importance of taking part in trials

Roger Dobson
BMJ 2007 335: 958. [Extract] [Full Text] [PDF]

Further lessons from the TGN1412 tragedy

Michael D E Goodyear
BMJ 2006 333: 270-271. [Extract] [Full Text] [PDF]

Hit parade
BMJ 2006 332: 1100. [Extract] [Full Text]

Count the harms

Fiona Godlee
BMJ 2006 332: 0. [Extract] [Full Text] [PDF]

Severe adverse reactions prompt call for trial design changes

Susan Mayor
BMJ 2006 332: 683. [Extract] [Full Text] [PDF]

My life as a guinea pig

Kate Mandeville
BMJ 2006 332: 735. [Extract] [Full Text]

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)
BMJ 2005 330: 1258. [Full Text] [PDF]

This article has been cited by other articles:

• Hall, R., de Antueno, C., Webber, A. (2007). Publication bias in the medical literature: a review by a Canadian Research Ethics Board: [Biais de publication dans la litterature medicale : un compte rendu d'un Comite d'ethique de recherche canadien]. Canadian J. Anesthesia 54: 380-388 [Abstract] [Full text]  
• de Jager, W., Hoppenreijs, E. P A H, Wulffraat, N. M, Wedderburn, L. R, Kuis, W., Prakken, B. J (2007). Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 66: 589-598 [Abstract] [Full text]  
• Mirowski, P. (2007). Johnny's in the basement, mixin' up the medicine. Review of Angell, Avorn, and Daemmrich on the modern pharmaceutical predicament.. Social Studies of Science 37: 311-327  
• Hallenbeck, J., del Zoppo, G., Jacobs, T., Hakim, A., Goldman, S., Utz, U., Hasan, A., for the Immunomodulation Workshop Participants, (2006). Immunomodulation Strategies for Preventing Vascular Disease of the Brain and Heart: Workshop Summary. Stroke 37: 3035-3042 [Abstract] [Full text]  
• Goodyear, M. D E (2006). Further lessons from the TGN1412 tragedy.. BMJ 333: 270-271 [Full text]  
• (2006). Hit parade. BMJ 332: 1100-1100 [Full text]  

Rapid Responses:

Read all Rapid Responses

Similarities and differences between men and mice

Dietmar Fuchs
bmj.com, 24 Mar 2006 [Full text]

Let us make Research More Personal - A Resident's Appeal

Suviraj James John
bmj.com, 25 Mar 2006 [Full text]

TGN 1412 and Bird flu

Evan L Lloyd
bmj.com, 27 Mar 2006 [Full text]

First do no harm: How safe are our clinical trials?

Sohil Ahmed Khan, et al.
bmj.com, 27 Mar 2006 [Full text]

Harm Reduction in Human Experimentation – Time to Revisit Research Governance.

Sati Ariyanayagam
bmj.com, 27 Mar 2006 [Full text]

Safety testing in animals deserves scrutiny

Kathy A Archibald
bmj.com, 31 Mar 2006 [Full text]

Governance of clinical research.

Alexander SD Spiers
bmj.com, 3 Apr 2006 [Full text]

Ultimate basis of the TGN1412 disaster

Duncan D Adams
bmj.com, 3 Apr 2006 [Full text]

TGN1412 - Did the striking nutritional contrasts between the rats and men contribute to the disaster?

Michael A. Crawford
bmj.com, 1 Aug 2006 [Full text]

Of Mice and Men and Pandora: Looking Back – Moving Forwards

Michael DE Goodyear
bmj.com, 12 Aug 2006 [Full text]

Re: Of Mice and Men and Pandora: Looking Back – Moving Forwards

Kathy A Archibald
bmj.com, 22 Aug 2006 [Full text]

Of Mice and Men and Pandora: Looking Back? Moving Forwards

Simon Festing
bmj.com, 26 Jun 2007 [Full text]